2015 American Transplant Congress
Clinical and Virologic Outcomes in High-Risk Adult EBV D+/R- Organ Transplant Recipients
Background:EBV D+/R- organ transplant recipients are a high risk group for developing PTLD. This subgroup of patients has been primarily evaluated in pediatric populations with…2015 American Transplant Congress
Three Year Outcomes of Renal Allograft Transplants in African American Recipients Receiving Alemtuzumab for Induction Immunosuppression
Ochsner Clinic Foundation, New Orleans, LA.
Background:Induction with Alemtuzumab is well documented to reduce the incidence and severity of acute rejection episodes, which may improve graft survival. Limited data are available…2015 American Transplant Congress
Long-Term Outcomes and Recurrence Risk of Four Common Primary Glomerular Diseases Following Transplantation
In the largest single center study of its kind, we assessed patient and allograft outcomes in 598 patients with the four most common causes of…2015 American Transplant Congress
Excellent Outcomes With Kidney Transplantation for Patients ≥70 Years of Age
BackgroundOur aim was to determine the outcomes following kidney transplantation in recipients ≥70 years of age at the time of transplantation.Materials and MethodsWe analyzed data…2015 American Transplant Congress
A Retrospective Study to Describe the Epidemiology and Outcomes of Opportunistic Infections After Solid Organ Transplantation
Background: Solid organ transplant (SOT) recipients are at increased risk for infections due to their complex medical conditions and use of immunosuppressive therapies. Despite significant…2015 American Transplant Congress
Birth Weight as a Marker of Nephron Mass: Impact on Renal Allograft Function
Nephron number has been considered a major determinant of renal allograft function and outcome. It has been demonstrated that low birth weights give rise to…2015 American Transplant Congress
Renal Transplantation in Aged Over 60 Years Demonstrates Compatible Clinical Outcomes to Younger Recipients
Introduction: The aim of this study was comparing clinical outcomes of kidney transplantation between aged over 60 years and younger recipientsMethods: From 1993 to 2013,…2015 American Transplant Congress
Safety and Outcome of Ganciclovir-Resistant CMV Treated With Foscarnet: A Single Center Retrospective Study
Background: Infection with cytomegalovirus (CMV) is an important cause of morbidity and mortality following solid organ transplantation (SOT). Resistance can rarely develop via mutations in…2015 American Transplant Congress
Standardizing Quality Improvement Practices in Pediatric Liver Transplantation: The SPLIT A3 Project
Quality improvement (QI) programs are key drivers of continual reform in process and patient safety, but at present, there are no pediatric liver transplant (PLT)-specific…2015 American Transplant Congress
Pancreas After Failed Islet Transplantation; a Successful Strategy to Maintain Insulin Independence
Introduction: As islet transplantation (tx) remains an experimental and uninsured procedure, there are no established protocols to achieve insulin independence following failure of the islet…
American Transplant Congress abstracts